Tomohiro Katsuya

13.5k total citations · 2 hit papers
171 papers, 6.8k citations indexed

About

Tomohiro Katsuya is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Tomohiro Katsuya has authored 171 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Cardiology and Cardiovascular Medicine, 57 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Molecular Biology. Recurrent topics in Tomohiro Katsuya's work include Hormonal Regulation and Hypertension (50 papers), Renin-Angiotensin System Studies (45 papers) and Blood Pressure and Hypertension Studies (32 papers). Tomohiro Katsuya is often cited by papers focused on Hormonal Regulation and Hypertension (50 papers), Renin-Angiotensin System Studies (45 papers) and Blood Pressure and Hypertension Studies (32 papers). Tomohiro Katsuya collaborates with scholars based in Japan, United States and United Kingdom. Tomohiro Katsuya's co-authors include Toshio Ogihara, Hiromi Rakugi, Mitsuru Ohishi, Jitsuo Higaki, Kazuhiko Ishikawa, Ken Sugimoto, Kōichi Yamamoto, Shunroku Baba, Jun Ogata and Yuxiao Fu and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Tomohiro Katsuya

168 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoadiponectinemia Is an Independent Risk Factor for Hypertension

2004 514 citations Tomohiro Katsuya, Kazuhiko Ishikawa et al. profile →
Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis

2020 176 citations Kazuomi Kario, Satoshi Hoshide et al. Circulation profile →

Peers

Countries citing papers authored by Tomohiro Katsuya

Since Specialization

Citations

This map shows the geographic impact of Tomohiro Katsuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Katsuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Katsuya more than expected).

Fields of papers citing papers by Tomohiro Katsuya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Katsuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Katsuya. The network helps show where Tomohiro Katsuya may publish in the future.

Co-authorship network of co-authors of Tomohiro Katsuya

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Katsuya. A scholar is included among the top collaborators of Tomohiro Katsuya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Katsuya. Tomohiro Katsuya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Home blood pressure-lowering effect of esaxerenone versus trichlormethiazide for uncontrolled hypertension: a predefined subanalysis of the EXCITE-HT randomized controlled trial by basal calcium channel blocker versus angiotensin receptor blocker 2024 ·Hypertension Research ·Kazuomi Kario, Hiroyuki Ohbayashi, (unknown), Naoki Itabashi, Mitsutoshi Kato, Kazuaki Uchiyama, (unknown), Noriko Nakamura, Takahide Miyamoto, Hirotaka Nagashima, Hidenori Ishida, Yusuke Ebe, Tsuguru Hatta, Toshiki Fukui, Tatsuo Shimosawa, Tomohiro Katsuya, Takashi Taguchi, (unknown), Mitsuru Ohishi, (unknown)	3
2	A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts 2024 ·Circulation Research ·Shota Yoshida, Hiroki Hayashi, (unknown), Shunsuke Katsuki, (unknown), (unknown), Jiao Sun, Ryo Nakamaru, Akiko Tenma, (unknown), Satoshi Baba, Munehisa Shimamura, Tomohiro Katsuya, Ryuichi Morishita, Hiromi Rakugi, Tetsuya Matoba, Hironori Nakagami	5
3	Digital therapeutic for hypertension improves physician-patient communication and clinical inertia: a survey of physicians who implemented CureApp HT in clinical practice 2024 ·Hypertension Research ·Tomohiro Katsuya, (unknown), Mitsuharu Aga, (unknown), Yusuke Takagi, (unknown), Tomoyuki Tanigawa	3
4	Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study 2024 ·Hypertension Research ·Tomohiro Katsuya, Yoshito Inobe, Kazuaki Uchiyama, Tetsuo Nishikawa, (unknown), Mitsutoshi Kato, Toshiki Fukui, Tsuguru Hatta, Arata Iwasaki, Hajime Ishii, Toshiyuki Sugiura, Takashi Taguchi, (unknown), (unknown), Tatsuo Shimosawa, (unknown)	13
5	Japan Geriatrics Society “Statement for the use of telemedicine in geriatric care: Telemedicine as a complement to in‐person medical practice”: Geriatric Medical Practice Committee consensus statement 2022 ·Geriatrics and gerontology international ·Kazushi Nomura, Satoru Ebihara, (unknown), Hiroyuki Umegaki, Kazuya Ooi, Sumito Ogawa, Tomohiro Katsuya, Yoshio Kobayashi, Takashi Sakurai, Mariko Miyao, Kiyoshi Yamaguchi, Masahiro Akishita	8
6	Poor glycemic control rather than types of diabetes is a risk factor for sarcopenia in diabetes mellitus: The MUSCLES‐DM study 2022 ·Journal of Diabetes Investigation ·Yoshihisa Hiromine, Shinsuke Noso, Hiromi Rakugi, Ken Sugimoto, Yasunori Takata, Tomohiro Katsuya, Masahiro Fukuda, Hiroshi Akasaka, Haruhiko Osawa, Yasuharu Tabara, Hiroshi Ikegami	17
7	Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis breakdown → 2020 ·Circulation ·Kazuomi Kario, Satoshi Hoshide, Hiroyuki Mizuno, Tomoyuki Kabutoya, Masafumi Nishizawa, Tetsuro Yoshida, (unknown), Tomohiro Katsuya, Yumiko Fujita, Osamu Okazaki, Yuichiro Yano, Naoko Tomitani, Hiroshi Kanegae, (unknown)	176
8	LATE BREAKING CLINICAL TRIAL (JCS 2017) : Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring : The NOCTURNE Study 2017 ·Japanese Circulation Journal-english Edition ·Kazuomi Kario, Naoko Tomitani, Hiroshi Kanegae, Hajime Ishii, Kazuaki Uchiyama, Kayo Yamagiwa, Toshihiko Shiraiwa, Tomohiro Katsuya, Tetsuro Yoshida, (unknown), Shinji Hasegawa, Satoshi Hoshide	3
9	Low alpha-synuclein levels in the blood are associated with insulin resistance 2015 ·Scientific Reports ·Gerardo Rodriguez‐Araujo, Hironori Nakagami, Yoichi Takami, Tomohiro Katsuya, Hiroshi Akasaka, Shigeyuki Saitoh, Kazuaki Shimamoto, Ryuichi Morishita, Hiromi Rakugi, Yasufumi Kaneda	32
10	–374 T/A Polymorphism inRAGEGene is Associated with Onset of Diabetes Mellitus, Atherosclerosis, and Renal Dysfunction in Patients with Hypertension 2012 ·Clinical and Experimental Hypertension ·Tatsuo Kawai, Kei Kamide, Norihisa Ito, Miyuki Onishi, Ryosuke Oguro, Yasushi Takeya, Yuji Tatara, Yoshihiro Maekawa, Tomohiro Katsuya, Mitsuru Ohishi, Hiromi Rakugi	9
11	Deletion of CDKAL1 Affects High-Fat Diet–Induced Fat Accumulation and Glucose-Stimulated Insulin Secretion in Mice, Indicating Relevance to Diabetes 2012 ·PLoS ONE ·Tadashi Okamura, Rieko Yanobu‐Takanashi, Fumihiko Takeuchi, Masato Isono, Koichi Akiyama, Yukiko Shimizu, Motohito Goto, (unknown), Ken Yamamoto, Tomohiro Katsuya, Akihiro Fujioka, Keizo Ohnaka, Ryoichi Takayanagi, Toshio Ogihara, Yukio Yamori, Norihiro Kato	26
12	Identification of Evidence Suggestive of an Association with Peripheral Arterial Disease at the OSBPL10 Locus by Genome-Wide Investigation in the Japanese Population 2010 ·Journal of Atherosclerosis and Thrombosis ·Hiroshi Koriyama, Hironori Nakagami, Tomohiro Katsuya, Ken Sugimoto, Hidetoshi Yamashita, Yoichi Takami, Shiro Maeda, Michiaki Kubo, Atsushi Takahashi, Yusuke Nakamura, Toshio Ogihara, Hiromi Rakugi, Yasufumi Kaneda, Ryuichi Morishita	25
13	Renal-Protective Effect of T- and L-Type Calcium Channel Blockers in Hypertensive Patients: An Amlodipine-to-Benidipine Changeover (ABC) Study 2007 ·Hypertension Research ·Mitsuru Ohishi, Takashi Takagi, Norihisa Ito, (unknown), Yuji Tatara, Norihiro Hayashi, Atsushi Shiota, Tomohiro Katsuya, Hiromi Rakugi, Toshio Ogihara	35
14	Rebound Weight Gain as Associated With High Plasma Norepinephrine Levels That Are Mediated Through Polymorphisms in the β2-Adrenoceptor 2005 ·American Journal of Hypertension ·Kazuko Masuo, Tomohiro Katsuya, Hiroshi Kawaguchi, Yuan Fu, Hiromi Rakugi, Takehide Ogihara, Matthew Tuck	30
15	A/C1166 Gene Polymorphism of the Angiotensin II Type 1 Receptor (AT1) and Ambulatory Blood Pressure: The Ohasama Study. 2003 ·Hypertension Research ·Masahiro Kikuya, Ken Sugimoto, Tomohiro Katsuya, Michiko Suzuki, Tomomi Sato, (unknown), (unknown), Itsuro Kazama, Mari Michimata, Tsutomu Araki, Atsushi Hozawa, Ichiro Tsuji, Toshio Ogihara, Teruyuki Yanagisawa, Yutaka Imai, Mitsunobu Matsubara	43
16	A common polymorphism of uncoupling protein 2 gene is associated with hypertension 2003 ·Journal of Hypertension ·(unknown), Hiroshi Ikegami, Tomomi Fujisawa, Yumiko Kawabata, Masaya Ono, Masanori Nishino, Mitsuru Ohishi, Tomohiro Katsuya, Hiromi Rakugi, Toshio Ogihara	65
17	Association of a Mast Cell Chymase Gene Variant with HDL Cholesterol, but not with Blood Pressure in the Ohasama Study 2002 ·Hypertension Research ·Masayuki Fukuda, Takayoshi Ohkubo, Tomohiro Katsuya, Atsushi Hozawa, Takashi Asai, Mitsunobu Matsubara, H Kitaoka, Ichiro Tsuji, Tsutomu Araki, Hiroshi Satoh, Jitsuo Higaki, Shigeru Hisamichi, Yutaka Imai, Toshio Ogihara	15
18	Deletion Polymorphism Of Angiotensin‐Converting Enzyme Gene Is Associated With Postprandial Hyperglycaemia In Individuals Undergoing General Check‐Up 2000 ·Clinical and Experimental Pharmacology and Physiology ·Mitsuru Ohishi, Hiromi Rakugi, Tetsuro Miki, Tomohiro Katsuya, Atsunori Okamura, Kei Kamide, Yukiko Nakata, (unknown), Hiroshi Ikegami, Yoshihiro Yanagitani, Yoshikatsu Tabuchi, Y Kumahara, Jitsuo Higaki, Toshio Ogihara	3
19	Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension 2000 ·Life Sciences ·Noriyuki Sato, Tomohiro Katsuya, Tsutomu Nakagawa, Kazuhiko Ishikawa, Yuxiao Fu, Takashi Asai, Masayuki Fukuda, (unknown), Yukio Nakamura, J Higaki, Toshio Ogihara	56
20	Association of Polymorphism in the Promoter Region of the Apolipoprotein E Gene with Diastolic Blood Pressure in Normotensive Japanese. 2000 ·Hypertension Research ·Tomohiro Katsuya, Noriyuki Sato, Takashi Asai, Masayuki Fukuda, Shin Takiuchi, Yuxiao Fu, (unknown), Atsushi Moriguchi, Hiromi Rakugi, Jitsuo Higaki, Toshio Ogihara	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact